UNII 2968PHW8QP

CITRIC ACID MONOHYDRATE

Unique Ingredient Identifier 2968PHW8QP is listed as a ingredient substance
Unii2968PHW8QP
Preferred Substance NameCITRIC ACID MONOHYDRATE
Rn5949-29-1
NcitC47452
Rxcui221079
Pubchem22230
Molecular FormulaC6H8O7.H2O
InchikeyYASYEJJMZJALEJ-UHFFFAOYSA-N
SmilesO.OC(=O)CC(O)(CC(O)=O)C(O)=O
Unii TypeINGREDIENT SUBSTANCE
RN5949-29-1
NCITC47452
RXCUI221079
PUBCHEM22230
MFC6H8O7.H2O
INCHI KEYYASYEJJMZJALEJ-UHFFFAOYSA-N
SMILESO.OC(=O)CC(O)(CC(O)=O)C(O)=O

Alternate Names

Dosage Forms

UNII 2968PHW8QP CITRIC ACID MONOHYDRATE is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,CNBLK INTRATHECALINJECTION0.02 %
AN,INFILTRATIONINJECTION0.16 %
AURICULAR (OTIC)SOLUTION1 %
AURICULAR (OTIC)SOLUTION, DROPS0.04 %
BUCCALFILM, SOLUBLE0.69 MG
BUCCALTABLET30 MG
CAUDAL BLOCKINJECTION20 %
EPIDURALINJECTION0.02 %
IM - IVINJECTABLE0.05 %
IM - IVINJECTION0.36 %
IM - IVINJECTION ADJ PH
IM - IVSOLUTION0.05 %
IM - IVSOLUTION, INJECTION0.088 %
IM - IV - SCINJECTABLE0.2 %
IM - IV - SCINJECTION1.26 %
IM - IV - SCSOLUTION, INJECTION2.2 MG/1ML
IM - SCINJECTION0.22 %
INFILTRATIONINJECTION0.02 %
INHALATIONAEROSOL, METERED0.002 MG/INH
INHALATIONINHALANT NA
INHALATIONSOLUTION4.2 MG/1ML
INHALATIONSOLUTION4.04 MG/INH
INHALATIONSUSPENSION, FOR INHALATION0.028 %
INTRA-AMNIOTICINJECTION0.1 %
INTRA-ARTERIALSOLUTION, INJECTION0.05 %
INTRA-ARTICULARINJECTION ADJPH
INTRA-ARTICULARINJECTION, SOLUTION ADJ PH
INTRABURSALINJECTION0.21 %
INTRABURSALINJECTION ADJPH
INTRACARDIACINJECTION2.5 mg/1mL
INTRACARDIACINJECTION1.05 %
INTRALESIONALINJECTION ADJPH
INTRAMUSCULARINJECTABLE0.5 %W/V
INTRAMUSCULARINJECTION4.67 mg/1mL
INTRAMUSCULARINJECTION2 %
INTRAMUSCULARINJECTION ADJPH
INTRAMUSCULARINJECTION, SOLUTION0.05 %W/V
INTRAMUSCULARINJECTION, SOLUTION ADJ PH
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION0.03 %
INTRAMUSCULARSOLUTION, INJECTION0.02 %
INTRAMUSCULARSOLUTION, INJECTION0.02 %W/V
INTRAMUSCULARSUSPENSION, EXTENDED RELEASE0.75 %
INTRAMUSCULARSUSPENSION, INJECTION0.75 %
INTRAOCULARINJECTION, SOLUTION, CONCENTRATE0.025 %
INTRAOCULARSOLUTION0.05 %
INTRAPLEURALINJECTION ADJPH
INTRAPLEURALPOWDER, FOR INJECTION SOLUTION0.03 %
INTRASYNOVIALINJECTION ADJPH
INTRATHECALINJECTION ADJPH
INTRATHECALPOWDER, FOR INJECTION SOLUTION0.03 %
INTRAVASCULARSOLUTION, INJECTION0.05 %
INTRAVENOUSINJECTABLE38.46 %
INTRAVENOUSINJECTABLE1.56 MG/1ML
INTRAVENOUSINJECTION5.25 MG/1ML
INTRAVENOUSINJECTION1 %
INTRAVENOUSINJECTION ADJ PH
INTRAVENOUSINJECTION, SOLUTION0.4 MG/1ML
INTRAVENOUSINJECTION, SOLUTION0.05 %
INTRAVENOUSINJECTION, SOLUTION ADJ PH
INTRAVENOUSLIQUID0.2 %
INTRAVENOUSLIQUID, CONCENTRATE, INJECTION0.053 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION50 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED384.6 mg
INTRAVENOUSSOLUTION0.5 %
INTRAVENOUSSOLUTION, CONCENTRATE0.003 %
INTRAVENOUSSOLUTION, INJECTION5.25 MG/1ML
INTRAVENOUSSOLUTION, INJECTION0.53 %
INTRAVENOUS INFUSIONINJECTION1 mg/1mL
IONTOPHORESISDRUG DELIVERY SYSTEM1.4 MG/PATCH
IONTOPHORESISPATCH, CONTROLLED RELEASE0.2 MG/PATCH
IONTOPHORESISSOLUTION0.02 %
IRRIGATIONINJECTION, SOLUTION, CONCENTRATE0.025 %
IV(INFUSION)INJECTION1.05 %
IV(INFUSION)LIQUID0.2 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION6.92 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED ADJPH
IV(INFUSION)SOLUTION, CONCENTRATE ADJPH
IV(INFUSION)SOLUTION, INJECTION0.38 %
NASALGEL NA
NASALSOLUTION0.28 %
NASALSOLUTION, SPRAY, METERED, PUMP0.006 %
NASALSPRAY200 MCG/SPRAY
NASALSPRAY2.6 MG/INH
NASALSPRAY1.7 MG/1ML
NASALSPRAY0.044 %
NASALSPRAY, METERED35 MG/INH
NASALSPRAY, METERED0.42 %
NERVE BLOCKINJECTION0.16 %
OPHTHALMICSOLUTION0.2 %
OPHTHALMICSOLUTION0.14 mg/1mL
OPHTHALMICSOLUTION, DROPS0.05 %
OPHTHALMICSUSPENSION ADJPH
ORALBAR, CHEWABLE500 MG
ORALCAPSULE119 MG
ORALCAPSULE, EXTENDED RELEASE18.8 MG
ORALCAPSULE, SOFT GELATIN1 MG
ORALCAPSULE, SUSTAINED ACTION, HARD GELATIN18.8 MG
ORALCONCENTRATE7 MG/1ML
ORALDROPS1.8 MG/1ML
ORALEMULSION NA
ORALFOR SUSPENSION5 MG/5ML
ORALGRANULE6.25 MG
ORALGRANULE, FOR ORAL SUSPENSION4.9 MG
ORALGRANULE, FOR RECONSTITUTION6 MG
ORALGRANULE, FOR SUSPENSION14.1 MG/5ML
ORALGRANULE, FOR SUSPENSION9.1 MG
ORALLIQUID13.5 MG/1ML
ORALPELLET4.9 MG
ORALPOWDER95 MG/1PKT
ORALPOWDER95 MG/1SCP
ORALPOWDER, FOR ORAL SOLUTION315 MG
ORALPOWDER, FOR ORAL SOLUTION1.74 G/16 OZ
ORALPOWDER, FOR ORAL SUSPENSION81 MG/1PKT
ORALPOWDER, FOR ORAL SUSPENSION81 MG/1SCP
ORALPOWDER, FOR RECONSTITUTION2.5 MG/5ML
ORALPOWDER, FOR SOLUTION120 MG/PKT
ORALPOWDER, FOR SUSPENSION140 MG/1ML
ORALSOLUTION53.1 mg
ORALSOLUTION24.85 MG/5ML
ORALSOLUTION7 MG/1ML
ORALSOLUTION ADJPH
ORALSOLUTION, ELIXIR100 MG/5ML
ORALSOLUTION, LIQUID10 MG/1000ML
ORALSOLUTION, LIQUID7 MG/1ML
ORALSOLUTION, SYRUP22.15 MG
ORALSPRAY10.24 MG/1SPR
ORALSUSPENSION70.32 MG/5ML
ORALSUSPENSION5.14 mg/1mL
ORALSUSPENSION, DROPS6 MG/2.5ML
ORALSUSPENSION, FOR INHALATION0.612 MG/2ML
ORALSUSPENSION, LIQUID8.98 MG/1ML
ORALSUSPENSION, SUSTAINED ACTION140.8 MG/1PKT
ORALSUSPENSION, SUSTAINED ACTION5 MG/5ML
ORALSUSPENSION, SYRUP, SUSTAINED ACTION60 MG/5ML
ORALSYRUP60 MG/5ML
ORALTABLET78 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED2.56 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE4.26 MG
ORALTABLET, CHEWABLE1.2 MG
ORALTABLET, COATED NA
ORALTABLET, DELAYED ACTION, ENTERIC COATED1 MG
ORALTABLET, EXTENDED RELEASE24 MG
ORALTABLET, FILM COATED42 MG
ORALTABLET, ORALLY DISINTEGRATING63 MG
ORALTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE3.08 MG
ORALTABLET, SUSTAINED ACTION, FILM COATED40 MG
ORALTABLET, UNCOATED, LOZENGE9.8 MG
ORALTABLET, UNCOATED, TROCHE12 MG
PARENTERALINJECTION0.05 %
PERIDURALINJECTION NA
RECTALEMULSION, AEROSOL FOAM0.29 %
RESPIRATORY (INHALATION)SUSPENSION, FOR INHALATION0.85 %W/V
SOFT TISSUEINJECTION ADJPH
SUBCUTANEOUSINJECTION2.5 mg/1mL
SUBLINGUALTABLET12 MG
TOPICALAEROSOL0.11 %W/W
TOPICALAEROSOL, FOAM0.1 %W/W
TOPICALCREAM0.055 %W/W
TOPICALCREAM0.01 %W/W
TOPICALCREAM, AUGMENTED0.05 %W/W
TOPICALCREAM, EMULSION, SUSTAINED RELEASE0.1 %W/W
TOPICALEMULSION0.11 %W/W
TOPICALEMULSION, AEROSOL FOAM0.11 %W/W
TOPICALEMULSION, CREAM0.44 %W/W
TOPICALEMULSION, CREAM0.18 %W/W
TOPICALEMULSION, LOTION0.05 %W/W
TOPICALGEL0.56 %W/W
TOPICALLIQUID NA
TOPICALLOTION0.85 %W/W
TOPICALOINTMENT0.012 %W/W
TOPICALPATCH, CONTROLLED RELEASE0.2 MG/PATCH
TOPICALPOWDER, FOR SOLUTION NA
TOPICALSHAMPOO2.3 %W/W
TOPICALSHAMPOO0.24 %W/W
TOPICALSHAMPOO, SUSPENSION0.25 %W/V
TOPICALSOLUTION0.19 %W/W
TOPICALSOLUTION0.01 %V/V
TOPICALSOLUTION, DROPS0.014 %W/V
TOPICALSWAB NA
TRANSDERMALDRUG DELIVERY SYSTEM1.4 MG/PATCH
TRANSDERMALFILM, EXTENDED RELEASE1.38 mg
VAGINALEMULSION, CREAM0.49 %
VAGINALSPONGE7.5 MG

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.